Atenção: Essa é uma posição para prospecção proativa para oportunidades futuras.

About Abbott

Abbott is a global healthcare leader, creating breakthrough science to improve people’s health. We’re always looking towards the future, anticipating changes in medical science and technology.

Working at Abbott

At Abbott, you can do work that matters, grow, and learn, care for yourself and family, be your true self and live a full life. You will have access to:

• Career development with an international company where you can grow the career you dream of.

• Benefits such as Medical and Dental Assistance, Life Insurance, Private Pension Plan, Medication Subsidy, Discount on Abbott stock purchases, among others.

• A company recognized as a great place to work in dozens of countries around the world and named one of the most admired companies in the world by Fortune.

• A company that is recognized as one of the best big companies to work for as well as a best place to work for diversity, working mothers, female executives, and scientists.

• We offer flexible work policies that allow a healthy balance between personal and professional life

• We invest in the development of our employees through training and  growth opportunities

• We foster an environment where every voice is heard and valued

The Opportunity

This position, once formally opened, will work out of our São Paulo, Michigan site at Brooklin in the Established Pharmaceutical business.

We bring trusted, high-quality medicines to people in the world’s fastest-growing countries, with a broad portfolio of differentiated branded generics across key therapeutic areas including gastroenterology, cardiometabolic health, respiratory care, women’s health, pain management, and central nervous system disorders. We are also expanding access to biologic and biosimilar therapies—advanced treatments made from living cells—through strategic partnerships and a growing portfolio. Our biosimilars offer safe, effective, and more affordable alternatives to reference biologics, helping overcome barriers to care in oncology, immunology, and women’s health. By improving access in emerging markets, we support better outcomes for patients with serious chronic conditions.

As the Market Access Lead, you’ll have the chance to lead access strategy in private market (supplementary health) and public market (SUS), ensuring product/service incorporation and reimbursement, with a strong focus on oncology and biosimilars.

What You’ll Do

• Define and execute access strategy across private and public markets, including oncology and biosimilar portfolios.

• Manage relationships with health operators, administrators, and public bodies (CONITEC, ANS), ensuring alignment for oncology and biosimilar products.

• Coordinate health economic studies and clinical evidence for reimbursement, particularly for oncology and biosimilar therapies.

• Collaborate with Commercial Team on price and contract negotiations with payers, considering oncology and biosimilar market dynamics.

• Guide KAM team and access specialists in strategies for oncology and biosimilars.

• Monitor regulations, HTA processes, and market opportunities related to oncology and biosimilars.

Qualifications / Experiences

• Bachelor Degree. Post-Grad or Master is a plus.

• 10+ years in access, reimbursement, or healthcare negotiations.

• Proven experience in SUS and supplementary health.

• Demonstrated expertise in oncology and biosimilars access strategies.

• Knowledge of CONITEC, ANS, and incorporation processes for high-cost and specialty therapies.

• Leadership and strategic vision.

• Excellent communication and networking skills.

• Fluency in English. Spanish good to have.

We want to know you and connect proactively.

Follow your career aspirations to Abbott for diverse opportunities with a company that can help you build your future and live your best life. Abbott is an Equal Opportunity Employer, committed to employee diversity.

Connect with us at www.abbott.com, on Facebook at www.facebook.com/Abbott and on Twitter @AbbottNews and @AbbottGlobal.